PHCentral: the difinitive internet resource for PAH information and support for Patients, Caregivers and Medical Professionals
Newsroom: Archives Index

August 29, 2008

  • Blood Test For Heart-Transplant Rejection Approved
    (TheHeart.org ) -- AlloMap measures the activity of genes related to allograft rejection, allowing patients to potentially avoid invasive endomyocardial biopsies and improving clinicians' ability to make management decisions.
  • Phen-Fen Lawyer Freed On Bail
    (Louisville Courier-Journal ) -- Cunningham is out on bail, which was lowered last week from $45 million to $1.25 million. Gallion, whose bond was reduced from $52 million to $2.5 million, is still in the Boone County Jail, where Cunningham had been held.
August 27, 2008 August 26, 2008
  • Pulmonary Hypertension Drug (Citrulline)
    (WHOI ) -- An earlier study found patients who received citrulline had lower rates of pulmonary hypertension compared to those who received a placebo treatment. Now, a larger, multi-national trial is underway to verify the effects of the drug.
August 25, 2008
  • Infection, Rejection, And Hospitalizations In Transplant Recipients Using Telehealth
    (RedOrbit ) -- Context-Telehealth technology serves individuals who live in geographical areas that prohibit easy access to specialized health care and can provide transplant recipients with access to transplant center personnel for adjunctive follow-up care. Objective-To compare infection, rejection, and hospitalization events in subjects randomized to telehealth or to standard posttransplant care.
  • Two Orlando Hospitals Win OK For Transplants
    (Orlando Sentinel ) -- The state gave approval Friday to the area's largest hospital chains -- Orlando Health and Florida Hospital -- to start the programs at their main facilities in town. Florida Hospital also was cleared to do lung transplants.
  • Judge Reduces Bail For Lawyers In Fen-Phen Case
    (Louisville Courier-Journal ) -- U.S. District Judge Danny Reeves reduced bail yesterday for William Gallion to $2.5 million, from $52 million; and to $1.25 million, from $45 million, for Shirley Cunningham Jr.
August 20, 2008
  • Thromboembolic PH May Respond To Sildenafil Over Long Term
    (Medscape/Reuters ) -- Statistically significant improvements were evident in several secondary endpoints -- namely, pulmonary vascular resistance, change in World Health Organization functional class, and quality of life based on the Cambridge Pulmonary Hypertension Outcomes Research Score (CAMPHOR).
  • Fruit Juice 'Could Affect Drugs'
    (BBC ) -- Drinking fruit juices may not be as healthy an option as thought - they could reduce the effectiveness of some medicines, it is being claimed.
August 19, 2008
  •   State Plan To Pay For Organ Donors’ Funerals
    (The West Australian ) -- The State Government would help cover the costs of organ donors’ funerals under a proposal promoted by Health Minister Jim McGinty and endorsed at an organ donation summit yesterday.
August 15, 2008 August 14, 2008
  • Bosentan Aids Treprostinil In PAH
    (Medscape/Reuters Health ) -- In certain patients with moderate-to-severe pulmonary artery hypertension (PAH), the addition of oral bosentan to subcutaneous treprostinil-based therapy can produce further clinical improvement, investigators report in the July issue of Chest.
August 13, 2008 August 12, 2008
  • Organ Donation 'Helps Families To Heal'
    (The Province ) -- Pia Henriksson of North Vancouver, whose son's organs saved five lives, supports a new B.C. study that shows 97 per cent of donor families are glad they gave.
August 11, 2008
  • Joyful Wedding For Lung Transplant Recipient
    (San Francisco Chronicle ) -- On Dec. 29, 2003, she underwent a double-lung transplant. Six years earlier, at age 20, she'd been diagnosed with pulmonary hypertension and Osler-Weber-Rendu syndrome, a genetic disorder.
August 8, 2008 August 6, 2008
  • Design Of The REVEAL Registry For US Patients With PAH
    (RedOrbit ) -- The Registry to Evaluate Early and Long-term PAH Disease Management (REVEAL) has been designed to meet the need for current information about patients with pulmonary arterial hypertension (PAH). The main objectives of REVEAL are to better define and understand PAH and to assess the consequences of treatment strategies.
  • Hi-Tech Projects Make Life Easier For Sufferers
    (RedOrbit ) -- The device directly removes carbon dioxide and adds oxygen to blood without using the lungs. The novel control system integrates with the body's natural control systems and, as patient oxygen demand increases, the device responds by providing oxygen faster and removing carbon dioxide faster.
August 5, 2008
  • Tracleer® Receives EU Approval For Treatment Of Patients With Mildly Symptomatic PAH
    (Actelion ) -- Tracleer® is the first PAH treatment ever to be investigated in a clinical study that exclusively enrolled patients with mildly symptomatic WHO FC II. This 185-patient randomized, double-blind, placebo-controlled study provided the basis for this EU approval. The indication extension reads: "Some improvements have also been shown in patients with PAH WHO functional class II (see section 5.1)"
  • Sleep Apnea Linked To Higher Risk Of Death
    (Medical News Today ) -- A US study that followed a random sample of men and women for 18 years showed that those with sleep apnea, where breathing pauses during sleep, had more than three times the risk of death from any cause compared to those who did not, and the risk went up when the condition was not treated.
  • Problems Managing Very Obese In Cath Lab Highlighted
    (MedWire News ) -- "Often, the risks for patient injury, substantial cost, and the loss of revenue from equipment failure dissuade cardiovascular interventional laboratories from performing these services on the very obese," explain Thomas Vanhecke and colleagues in the American Journal of Cardiology.



Powered by Coranto



Advanced Search

Need Webboard help? Frequently asked Questions

 

 

 

 

Recently Diagnosed? Medical Issues Coping With PAH Financial Topics Newsroom
Talk Action Central Features Contribute Recognition Links Books

Help Search Site Map About PHC Disclaimer Contact Us

HOME

Recently diagnosed?
Medical Issues
Coping With PAH
Financial Issues
Newsroom
Talk
Action Central
Features
Contribute
Recognition
PAH Resources
Actelion
Platinum Plus Sponsor
 
Advertisement:

Support PHCentral
Click here to buy Amazon products
This website is accredited by Health On the Net Foundation. Click to verify.
We comply with the HONcode standard for trustworthy health
information:
verify here.